Business profile

Roche Oy

Roche Oy's registered office is Esbo. It is a limited company. The company was established on 1983-08-04. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €81,416,384 and operating profit was €2,276,100.

Business ID 0498521-4ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
0498521-4
Sector
Wholesale of pharmaceutical goods
Municipality
Esbo
Company form
Limited company
Registration date
1983-08-04
Business ID registration date
1983-02-01
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Revontulenpuisto 2 C, 02100, Esbo

Postal address: P.O. Box 112, 02101, Esbo

Phone: +35810554511Source observation

Website: https://www.roche.fiSource observation

Instagram profile: https://www.instagram.com/rocheSource: company website

X profile: https://x.com/RocheFinlandSource: company website

Facebook profile: https://www.facebook.com/rochesuomiSource: company website

Linkedin profile: https://www.linkedin.com/company/roche-finland?trk=hb_tab_compy_id_1602Source: company website

People and decision-makers

Ariane LosadaDecision-maker

Email: Email available for logged-in usersSource: company website

Phone: Phone available for logged-in usersSource: company website

Janina HaapaniemiPublic Affairs Manager

Email: Email available for logged-in usersSource: company website

Phone: Phone available for logged-in usersSource: company website

Direct contact details available for logged-in usersSome person-level contact details are shown only to registered users. The data is based on public sources, such as the company's own website.Log in to view decision-maker contact details

About Roche Oy

Financial position and key figures for the company.

Roche Oy's location municipality is Esbo. It is a limited company. The company was established on 1983-08-04. It operates in the industry of wholesale of pharmaceutical goods. In its latest retained statement for 2025-12-31, revenue was €81,416,384 and operating profit was €2,276,100. The latest retained financial statement for 2025-12-31 shows revenue of €81,416,384 and profit for the financial year of €1,877,357. Based on the latest retained statement, revenue growth was +3.8%, operating margin was +2.6%, and equity ratio was +23.4%.

Financial highlights

Key figures from the latest financial period.

Latest financial period

2025-12-31

Imported periods0
PRH parsed0
Profile sourceEnriched source observation
Derived indicators
Revenue growth3.8%
Operating margin2.6%
Equity ratio23.4%
Revenue€81,416,384+€2,952,156 (+3.8%) vs previous periodPrevious: €78,464,228
Operating profit (loss)€2,276,100+€40,995 (+1.8%) vs previous periodPrevious: €2,235,105
Profit (loss) for the financial year€1,877,357-€2,287 (-0.1%) vs previous periodPrevious: €1,879,644
Assets€38,571,315-€1,457,272 (-3.6%) vs previous periodPrevious: €40,028,588
Balance-sheet contextLatest financial period
Revenue trend4 periods
€70,856,584
2022-12-31
€71,980,638
2023-12-31
€78,464,228
2024-12-31
€81,416,384
2025-12-31
Operating profit (loss) trend4 periods
€2,985,704
2022-12-31
€2,795,538
2023-12-31
€2,235,105
2024-12-31
€2,276,100
2025-12-31
Profit (loss) for the financial year trend4 periods
€2,385,064
2022-12-31
€2,193,942
2023-12-31
€1,879,644
2024-12-31
€1,877,357
2025-12-31
Assets trend4 periods
€27,850,818
2022-12-31
€29,186,658
2023-12-31
€40,028,588
2024-12-31
€38,571,315
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: Rikastettu lähdehavainto.

Equity ratioPassable
29/100 · Declining
23.4 %2024-12-31: 30.4 %
Current ratioNot assessable
0/100 · Trend unavailable
Not available2024-12-31: Ei saatavilla
Operating profit marginPassable
57/100 · Declining
2.6 %2024-12-31: 2.7 %
Ratio history
Ratio2022-12-312023-12-312024-12-312025-12-31
Equity ratio47.0 %35.2 %30.4 %23.4 %
Current ratio----
Operating profit margin3.9 %3.6 %2.7 %2.6 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID0498521-4
VAT IDFI04985214
EU IDFIFPRO.0498521-4
MunicipalityEsbo
Current registered entries
1983-01-01Registered in Tax Administration (Employer Register)
1983-02-01Registered in Tax Administration (Tax Administration)
1983-08-04Registered in Patent and Registration Office (Trade Register)
1994-06-01VAT-liable for business activity in Tax Administration (VAT Register)
1995-03-01Registered in Tax Administration (Prepayment Register)

Responsible people

Public role relationships materialized from source observations.

Direct contact details available for logged-in users.

Slater LisaToimitusjohtajaSources: 4 · Confidence: 78%
Joerin Isabel MariannePuheenjohtajaSources: 3 · Confidence: 78%
Ogochi Kamiya Patricia MayumiVarsinainen jäsenSources: 4 · Confidence: 78%
Hassan Ehab Abdelmoneim YoussefVarsinainen jäsenSources: 3 · Confidence: 78%
Martin Wiliam George HaswellGeneral Manager, Roche Pharma NorwaySources: 1 · Confidence: 76%
Linnankivi Anssi PekkaProkuristiSources: 1 · Confidence: 78%
Korpelainen Tiina MariaProkuristiSources: 1 · Confidence: 78%
Manner-Raappana Anna HelenaProkuristiSources: 1 · Confidence: 78%
Lintunen Elisa MarittaProkuristiSources: 1 · Confidence: 78%
Slater LisaVarsinainen jäsenSources: 1 · Confidence: 78%
Mao HongliProkuristiSources: 1 · Confidence: 78%
Berolla JergosClinical Trial PartnerSources: 1 · Confidence: 76%
Petra PörnullPäävastuullinen tilintarkastajaSources: 1 · Confidence: 76%

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
B1
StableRoche Oy
Model score60/100
Assessment confidenceMedium
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectoryFinancial development is mostly stable or mixed.
4 comparable periods
RevenueStable
ProfitabilityStable
SolvencyDeteriorating
LiquidityNot enough history
Peer comparisonSame industryDescriptive comparison – does not change the model score.
66 peers
Solvency23%
Below 77% of peers
Profitability58%
Better than 58% of peers
Revenue growth71%
Better than 71% of peers
Supporting factors
  • Active registered status
  • A newer financial statement filing has been reported
  • Long registry continuity
Risk factors to note
  • Elevated industry distress context
Automatic model gradeB1
Automatic model snapshot2026-09-17
Automatic model versionopen-risk-grade-v0.14
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskelevated
45/100

Industry context is elevated based on normalized open statistical inputs.

Age and continuityVakiintunut
90/100

The company has about 43 years of registry continuity.

Registry and status signalsSeurattava
70/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
17 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

44 register eventsLatest event: 2026-05-08

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Roche Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.